top of page

Moonwalk Biosciences raises $57 million today to pursue epigenome engineering

Co-Founder and CEO Alex Aravanis describes how epigenetic engineering could have advantages over gene editing and why he thinks Moonwalk's 'complete view' of the epigenome could give it an edge in this space.


Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight


Breakthrough Properties is a life science real estate company that is exclusively focused on delivering cutting-edge environments for the life science industry. With a portfolio of roughly 5 million square feet across the US, UK and continental Europe, Breakthrough has emerged as a leading partner for high-growth biotechs and pharmas around the world. 

bottom of page